Peroxisome proliferator-activated receptor γ is required for CD4 + T cell-mediated lymphopenia-associated autoimmunity

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4161-4169

  Housley, William J ^a   Adams, Catherine O ^a   Vang, Amanda G ^a   Brocke, Stefan ^a   Nichols, Frank C ^a   LaCombe, Melissa ^a   Rajan, Thiruchandurai V ^a   Clark, Robert B ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMING RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME ACTIVATION; FEMALE; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN; T EFFECTOR CELL;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; LYMPHOPENIA; MICE; MICE, KNOCKOUT; PPAR GAMMA;

EID: 80054747182     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101731     Document Type: Article

References (39)

1. Straus, D. S., and C. K. Glass. 2007. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 28: 551-558. (Pubitemid 350101420)
2. Clark, R. B., D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S. J. Padula. 2000. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J. Immunol. 164: 1364-1371. (Pubitemid 30067250)
3. Faveeuw, C., S. Fougeray, V. Angeli, J. Fontaine, G. Chinetti, P. Gosset, P. Delerive, C. Maliszewski, M. Capron, B. Staels, et al. 2000. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett. 486: 261-266.
4. Harris, S. G., and R. P. Phipps. 2001. The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur. J. Immunol. 31: 1098-1105.
5. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82. (Pubitemid 28079218)
6. Housley, W. J., C. A. O'Conor, F. Nichols, L. Puddington, E. G. Lingenheld, L. Zhu, and R. B. Clark. 2009. PPARgamma regulates retinoic acid-mediated DC induction of Tregs. J. Leukoc. Biol. 86: 293-301.
7. Chung, S. W., B. Y. Kang, and T. S. Kim. 2003. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor. Mol. Pharmacol. 64: 1169-1179. (Pubitemid 37310750)
8. Yang, X. Y., L. H. Wang, T. Chen, D. R. Hodge, J. H. Resau, L. DaSilva, and W. L. Farrar. 2000. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J. Biol. Chem. 275: 4541-4544. (Pubitemid 30108833)
9. Klotz, L., S. Burgdorf, I. Dani, K. Saijo, J. Flossdorf, S. Hucke, J. Alferink, N. Nowak, M. Beyer, G. Mayer, et al. 2009. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. [Published erratum appears in 2009 J. Exp. Med. 206: 3159.] J. Exp. Med. 206: 2079-2089.
10. Lei, J., H. Hasegawa, T. Matsumoto, and M. Yasukawa. 2010. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells. J. Immunol. 185: 7186-7198.
11. Wohlfert, E. A., F. C. Nichols, E. Nevius, and R. B. Clark. 2007. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J. Immunol. 178: 4129-4135. (Pubitemid 46492362)
12. Hontecillas, R., and J. Bassaganya-Riera. 2007. Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis. J. Immunol. 178: 2940-2949. (Pubitemid 46333173)
13. Bassaganya-Riera, J., K. Reynolds, S. Martino-Catt, Y. Cui, L. Hennighausen, F. Gonzalez, J. Rohrer, A. U. Benninghoff, and R. Hontecillas. 2004. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791. (Pubitemid 39208411)
14. Beales, P. E., R. Liddi, A. E. Giorgini, A. Signore, E. Procaccini, K. Batchelor, and P. Pozzilli. 1998. Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse. Eur. J. Pharmacol. 357: 221-225. (Pubitemid 28439198)
15. Diab, A., C. Deng, J. D. Smith, R. Z. Hussain, B. Phanavanh, A. E. Lovett-Racke, P. D. Drew, and M. K. Racke. 2002. Peroxisome proliferator- activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168: 2508-2515. (Pubitemid 34171857)
16. Feinstein, D. L., E. Galea, V. Gavrilyuk, C. F. Brosnan, C. C. Whitacre, L. Dumitrescu-Ozimek, G. E. Landreth, H. A. Pershadsingh, G. Weinberg, and M. T. Heneka. 2002. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51: 694-702. (Pubitemid 34568847)
17. Mueller, C., V. Weaver, J. P. Vanden Heuvel, A. August, and M. T. Cantorna. 2003. Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. Arch. Biochem. Biophys. 418: 186-196. (Pubitemid 37159385)
18. Woerly, G., K. Honda, M. Loyens, J. P. Papin, J. Auwerx, B. Staels, M. Capron, and D. Dombrowicz. 2003. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J. Exp. Med. 198: 411-421. (Pubitemid 36976052)
19. Dubuquoy, L., C. Rousseaux, X. Thuru, L. Peyrin-Biroulet, O. Romano, P. Chavatte, M. Chamaillard, and P. Desreumaux. 2006. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 55: 1341-1349. (Pubitemid 44277368)
20. Pershadsingh, H. A. 2004. Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis? Expert Opin. Investig. Drugs 13: 215-228. (Pubitemid 38351343)
21. Pershadsingh, H. A., M. T. Heneka, R. Saini, N. M. Amin, D. J. Broeske, and D. L. Feinstein. 2004. Effect of pioglitazone treatment in a patient with secondary multiple sclerosis. J. Neuroinflammation 1: 3.
22. Drew, P. D., J. Xu, and M. K. Racke. 2008. PPAR-gamma: Therapeutic Potential for Multiple Sclerosis. PPAR Res. 2008: 627463.
23. Khoruts, A., and J. M. Fraser. 2005. A causal link between lymphopenia and autoimmunity. Immunol. Lett. 98: 23-31. (Pubitemid 40409815)
24. Zandman-Goddard, G., and Y. Shoenfeld. 2002. HIV and autoimmunity. Autoimmun. Rev. 1: 329-337. (Pubitemid 38340245)
25. Coles, A. J., M. Wing, S. Smith, F. Coraddu, S. Greer, C. Taylor, A. Weetman, G. Hale, V. K. Chatterjee, H. Waldmann, and A. Compston. 1999. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354: 1691-1695. (Pubitemid 29533060)
26. McKenzie, I. F., G. M. Morgan, M. S. Sandrin, M. M. Michaelides, R. W. Melvold, and H. I. Kohn. 1979. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J. Exp. Med. 150: 1323-1338. (Pubitemid 10132051)
27. Housley, W. J., C. O. Adams, F. C. Nichols, L. Puddington, E. G. Lingenheld, L. Zhu, T. V. Rajan, and R. B. Clark. 2011. Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function. J. Immunol. 186: 6779-6787.
28. Feng, X., H. Wang, H. Takata, T. J. Day, J. Willen, and H. Hu. 2011. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat. Immunol. 12: 544-550.
29. Blazar, B. R., A. H. Sharpe, P. A. Taylor, A. Panoskaltsis-Mortari, G. S. Gray, R. Korngold, and D. A. Vallera. 1996. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. J. Immunol. 157: 3250-3259. (Pubitemid 126449134)
30. Sprent, J., C. D. Surh, D. Agus, M. Hurd, S. Sutton, and W. R. Heath. 1994. Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells. J. Exp. Med. 180: 307-317. (Pubitemid 24181079)
31. Yoshida, M., T. Watanabe, T. Usui, Y. Matsunaga, Y. Shirai, M. Yamori, T. Itoh, S. Habu, T. Chiba, T. Kita, and Y. Wakatsuki. 2001. CD4 T cells monospecific to ovalbumin produced by Escherichia coli can induce colitis upon transfer to BALB/c and SCID mice. Int. Immunol. 13: 1561-1570. (Pubitemid 33133883)
32. Rahman, A. H., R. Zhang, C. D. Blosser, B. Hou, A. L. Defranco, J. S. Maltzman, E. J. Wherry, and L. A. Turka. 2011. Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88. Blood 117: 3123-3130.
33. Clark, R. B. 2002. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71: 388-400.
34. Wang, Y. L., K. A. Frauwirth, S. M. Rangwala, M. A. Lazar, and C. B. Thompson. 2002. Thiazolidinedione activation of peroxisome proliferator- activated receptor gamma can enhance mitochondrial potential and promote cell survival. J. Biol. Chem. 277: 31781-31788.
35. Schmidt, M. V., P. Paulus, A. M. Kuhn, A. Weigert, V. Morbitzer, K. Zacharowski, V. A. Kempf, B. Brune, and A. von Knethen. 2011. PPAR{gamma}-Induced T-Cell Apoptosis Reduces Survival During Polymicrobial Sepsis. Am. J. Respir. Crit. Care Med. 184: 64-74.
36. Soller, M., A. Tautenhahn, B. Brüne, K. Zacharowski, S. John, H. Link, and A. von Knethen. 2006. Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis. J. Leukoc. Biol. 79: 235-243. (Pubitemid 43054269)
37. Jo, S. H., C. Yang, Q. Miao, M. Marzec, M. A. Wasik, P. Lu, and Y. L. Wang. 2006. Peroxisome proliferator-activated receptor gamma promotes lymphocyte survival through its actions on cellular metabolic activities. J. Immunol. 177: 3737-3745. (Pubitemid 44359906)
38. Yang, C., S. H. Jo, B. Csernus, E. Hyjek, Y. Liu, A. Chadburn, and Y. L. Wang. 2007. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. Am. J. Pathol. 170: 722-732. (Pubitemid 47339406)
39. Chaturvedi, R. K., and M. F. Beal. 2008. PPAR: a therapeutic target in Parkinson's disease. J. Neurochem. 106: 506-518.